Beta Finch - S&P 100 - EN

Top 100 US-listed companies by market capitalization. AI-powered earnings call analysis for S&P 100 (SP100). Two AI hosts break down quarterly results, key metrics, and market implications in digestible podcast episodes.

Beta Finch - S&P 100 - EN is a business podcast hosted by Unknown Host, with 0 episodes on record and a Required Pod Score of 83. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

Unknown Host hosts Beta Finch - S&P 100 - EN, a business show with 0 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  Beta Finch - S&P 100 - EN

  Oracle Q1 2027 Earnings Analysis

  Sep 11, 20266 min

  More earnings analysis: https://betafinch.com Groups: AI_LEADERS ( https://betafinch.com/groups/AI_LEADERS) ────────── WELCOME TO BETA FINCH, your AI-powered earnings breakdown of the companies moving markets. I'm Alex. JORDAN: And I'm Jordan. Today we're digging into Oracle's fiscal Q1 2027 report, and Alex, this one's got some big numbers in it. ALEX: It really does — but before we get into it, quick reminder: this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions. JORDAN: Good, now let's get into it because Oracle's CFO Hilary Maxson used the word "acceleration" to describe the quarter, and honestly, the numbers back that up. ALEX: Total revenue hit a record $19.3 billion, up 30% year-over-year. What's notable is that revenue actually grew sequentially from Q4 to Q1 — historically that hasn't happened for Oracle. A strong Q4 usually meant a softer Q1. JORDAN: Right, and the real engine here is cloud infrastructure — OCI revenue was $7.4 billion, up 121% year-over-year. That's after 93% growth last quarter, so this business is actually speeding up, not slowing down. ALEX: Cloud apps grew a more modest 10%, but within that, Fusion grew 14% and industry apps grew over 20%. Non-GAAP EPS came in at $1.92, up 30%. And then there's the RPO number — remaining performance obligations jumped $26 billion in just one quarter. JORDAN: That RPO detail is worth pausing on. Management said the vast majority of that new backlog came through prepayments or "bring your own hardware" arrangements — meaning it doesn't require Oracle to put up more of its own capital. They now expect about half of total RPO to convert into revenue over the next 36 months. ALEX: Which matters a lot for the CapEx conversation, because Oracle spent $28 billion in CapEx this quarter alone, leading to negative free cash flow of $5 billion. Full-year CapEx guidance stays at $90-95 billion. JORDAN: On the Q&A, one exchange stood out to me — an analyst pushed CFO Hilary Maxson on when free cash flow turns positive again. She wouldn't give a timeline but said each data center project, once ramped, converts to free cash flow at close to 100% of post-tax EBITDA, essentially calling the business "self-funding" over time. ALEX: There was also a good back-and-forth on gross margins, which declined this quarter as expected. Maxson was pretty clear that operating margin — which held flat around 42% — is the metric she wants investors focused on, not gross margin, since the infrastructure business is structurally lower-margin but requires much less R&D and sales spend. JORDAN: On the infrastructure side, Co-CEO Clay Magouyrk shared some eye-popping delivery stats — 850 megawatts of AI capacity and over 300,000 GPUs delivered since Q4, almost triple what they delivered in all of Q4. GPU utilization sits at 97.9%, and — this one surprised me — GPUs coming up for renewal are actually being renewed or resold at a 20% premium to their original contracts. ALEX: That's a strong signal on hardware longevity in a market that's been nervous about AI infrastructure depreciation. Magouyrk also addressed concerns about delays at the New Mexico and Wisconsin data centers directly, saying neither will impact fiscal 2027 revenue guidance, and stressed Oracle has a broad, diversified pipeline of sites so no single delay creates a major hit. JORDAN: On the apps side, Co-CEO Mike Sicilia leaned into the AI-agents story — customers used embedded AI capabilities more than 150 million times in the quarter, AI agents executed 3.5 million times in production, nearly doubling quarter-over-quarter, and there are now over 2,300 AI agents live with customers, up 90% sequentially. ALEX: They also announced NetSuite Next, a new AI-infused version of NetSuite, and noted their AI Connector Service link This episode includes AI-generated content.

  ListenShow Notes
• 

  Beta Finch - S&P 100 - EN

  Broadcom Q3 2026 Earnings Analysis

  Sep 3, 20267 min

  More earnings analysis: https://betafinch.com Groups: CHIPS ( https://betafinch.com/groups/CHIPS) , AI_LEADERS ( https://betafinch.com/groups/AI_LEADERS) ────────── WELCOME TO BETA FINCH, your AI-powered earnings breakdown. I'm Alex, joined as always by Jordan, and today we're digging into Broadcom's fiscal Q3 2026 numbers—and folks, these are some genuinely wild numbers. ALEX: Before we get into it, quick reminder: this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions. JORDAN: And it's a good quarter to have that disclaimer front and center, because Hock Tan basically stood up and said "we're just getting started," and then backed it up with a $230 billion revenue forecast for 2028. ALEX: Let's start with the headline numbers. Q3 revenue came in at $29.6 billion, up 86% year-on-year. Operating income hit $20.1 billion, up 92%, with a record 68% operating margin. And free cash flow? $13.7 billion, 46% of revenue. JORDAN: Those margins are the story for me. Gross margin actually dipped slightly, down to about 75%, because AI chips carry more memory content and lower margins than the rest of the business. But operating margin still climbed because revenue is growing so much faster than expenses. That's operating leverage doing exactly what it's supposed to do. ALEX: Right, and the AI piece specifically—AI semiconductor revenue was $16.7 billion for the quarter, more than tripling year-over-year. That's now 56% of total revenue, up from 49% just last quarter. JORDAN: This company has essentially transformed into an AI infrastructure company that happens to also sell broadband chips and VMware software. ALEX: Speaking of which, let's talk customers, because this is where it gets interesting. Broadcom has six custom AI chip customers, but Hock Tan really zeroed in on four: Google, Anthropic, OpenAI, and Meta. JORDAN: The Google relationship is the elder statesman here—a decade of TPU development, and they just signed a long-term deal for "multi-tens of billions of dollars" of TPUs annually. They shipped the new Ironwood TPU v7 this quarter and are already ramping the next-gen v8i. ALEX: But the real headline is Anthropic. Tan said Anthropic is on track to become Broadcom's largest XPU customer in 2027, deploying 5 gigawatts of TPU v8i next year and then 10 more gigawatts in 2028. JORDAN: And OpenAI isn't far behind—their custom chip, nicknamed Jalapeño, is already reportedly outperforming Nvidia's Grace Blackwell in inference workloads at, according to Tan, less than half the cost. OpenAI's on pace for over 5 gigawatts by 2028, making them Broadcom's second-largest customer. ALEX: That "half the cost" line is the thesis of the whole call, honestly. Custom silicon, co-designed for a specific model's workload, beats a general-purpose GPU on performance and cost. That's Broadcom's pitch to the market. JORDAN: Now let's talk about the number that got everyone's attention: guidance. Q4 AI revenue guided to $21.7 billion, up 236% year-on-year. Full fiscal 2026 AI revenue now expected at $58 billion. ALEX: And then they went further than usual—giving multi-year guidance. AI revenue is expected to double to $115 billion in fiscal 2027, then double again to $230 billion in fiscal 2028. JORDAN: That's an unusually bold move for a company to lock in two years out. And CFO Amie Thuener was clear they don't plan to update it quarterly—so this is a stake in the ground, not a rolling estimate. ALEX: On the Q&A, analysts pushed hard on whether that's really achievable. Stacy Rasgon from Bernstein did some math on gigawatts versus dollars, and Tan clarified something important: not all the gigawatt capacity they've outlined will necessarily be "deployed" in that window—some of it depends on data centers, power, and shells being physically r This episode includes AI-generated content.

  ListenShow Notes
• 

  Beta Finch - S&P 100 - EN

  Palo Alto Networks Q4 2026 Earnings Analysis

  Sep 2, 20267 min

  More earnings analysis: https://betafinch.com ────────── WELCOME TO BETA FINCH — PANW Q4 FY2026 ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, here with Jordan, and today we're digging into Palo Alto Networks' fiscal Q4 2026 results. This one's a big report to close out their fiscal year. JORDAN: Before we jump in — this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions. ALEX: Right, so let's get into it, because Palo Alto had a genuinely record quarter. RPO — that's remaining performance obligations, basically the backlog of contracted future revenue — crossed $20 billion for the first time, landing at $21.2 billion, up 34%. JORDAN: And the number that really jumped out to me was Next-Generation Security ARR, or NGS ARR, hitting $9.1 billion, up 63%. They added almost $1 billion in net new NGS ARR in a single quarter. CFO Dipak Golechha pointed out that's roughly what the entire company's NGS ARR was back in his first quarter as CFO in 2021. That's the kind of comparison that really puts scale into perspective. ALEX: Total revenue for the quarter was $3.41 billion, up 34%, and full-year revenue came in at $11.5 billion, up 24%. Non-GAAP EPS beat guidance at $1.02, and operating margin for the year expanded to 29.2%. JORDAN: What's notable is that margin expansion happened while they were digesting their two biggest acquisitions ever — CyberArk, now rebranded Idira, and Chronosphere. Usually big M&A drags on margins for a while, but management said CyberArk's cost synergies are three to six months ahead of schedule. ALEX: Let's talk strategy, because CEO Nikesh Arora spent a lot of time on what he called three AI "inflection points" over the last several months — the shift from prompting to autonomous agents, the "Mythos moment" where AI models got scary good at finding vulnerabilities, and now a move toward open-weight, sovereign AI models. His overall thesis: all three point toward the same conclusion. JORDAN: Which is platformization — get customers to consolidate onto one unified security architecture instead of stitching together point products. They hit about 220 net new "platformizations" in the quarter, more than double the pace from two years ago, and platformized customers are showing net revenue retention above 120%. ALEX: They also called out some serious deal sizes — a $126 million deal with a global telecom, $72 million with an IT services firm, $53 million with a payments company. And Prisma AIRS, their AI security product, crossed $100 million in ARR in just four quarters — fastest product scale in company history. JORDAN: XSIAM, their security operations platform, is also cruising — over $700 million in ARR, up 70%, past 1,000 customers. And on the observability side, since closing Chronosphere, that ARR has more than doubled past $500 million. Combined, XSIAM and observability are now a billion-dollar-plus business that basically didn't exist a few years ago. ALEX: There was also a bit of breaking news on the call — they closed an acquisition of a company called Console the same day, focused on AI-driven IT and security operations, folding into their Cortex team. JORDAN: On the Q&A side, I thought the most candid moment was Nikesh basically saying M&A isn't a strategy for them — it's a consequence of watching 40 or 50 funded startups and jumping in when one of them nails a technology shift before Palo Alto's internal roadmap gets there. Refreshingly blunt for a CEO. ALEX: There was also a fun exchange about the CyberArk integration — a new "Modern PAM" product just went GA, and Nikesh made the case that identity security for AI agents and machine identities is a wide-open category with no established leader yet, which is where he thinks Idira has a real head start. JORDAN: This episode includes AI-generated content.

  ListenShow Notes
• 

  Beta Finch - S&P 100 - EN

  Medtronic Q1 2027 Earnings Analysis

  Sep 1, 20267 min

  More earnings analysis: https://betafinch.com Groups: HEALTHCARE ( https://betafinch.com/groups/HEALTHCARE) ────────── WELCOME TO BETA FINCH — MEDTRONIC Q1 FY2027 ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, joined as always by Jordan, and today we're digging into Medtronic's fiscal 2027 first quarter — and it's a big one. JORDAN: Yeah, a lot to unpack here. Big beats, a couple of surprise M&A announcements, and a robotics story that's getting more interesting by the day. ALEX: Before we jump in, quick note — this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions. JORDAN: With that out of the way, let's get into the numbers, because they were strong. ALEX: $9.8 billion in revenue, up 13.7% organically, adjusted EPS of $1.45 — both well ahead of what analysts were expecting. Now, a chunk of that growth came from an accounting quirk: fiscal 2027 is a 53-week year, and that extra week added about 670 basis points to growth this quarter. JORDAN: Right, but even stripping that out, CFO Thierry Piéton said it was their strongest quarterly performance in nearly eight years, excluding COVID comparisons. So this wasn't just a calendar trick — the underlying business is actually accelerating. ALEX: And it was broad-based. CEO Geoff Martha kept hammering that point — it's not one hot product carrying the quarter, it's basically every major business line pulling its weight. JORDAN: The headline story, though, is Cardiac Ablation Solutions — CAS. That business grew 88% worldwide, 139% in the U.S. They crossed $2 billion in trailing twelve-month revenue, ahead of schedule. Their Sphere-9 catheter picked up nine points of U.S. market share this quarter alone. ALEX: Nine points in one quarter is wild for medtech. JORDAN: It really is. And they're guiding CAS to grow at 2.5 times the broader electrophysiology market for the full year — even upgraded that to more than 3x for Q2. The U.S. installed base for their Affera system grew 35% sequentially, on top of 40% the quarter before. ALEX: Which tells you they're nowhere near saturated. Management said 75% of that installed base is still concentrated in high-volume hospital centers, so there's a long runway into smaller accounts. JORDAN: Beyond CAS, Cardiac Rhythm Management grew 15%, Cranial & Spinal Technologies grew 13%, and Surgical — their biggest unit at over $6 billion a year — grew 9%. Pelvic health jumped 15%, largely thanks to Altaviva, where procedures doubled sequentially. ALEX: Now let's talk strategy, because Medtronic made two acquisition-adjacent announcements the same morning as earnings. First, a $700 million strategic investment and distribution deal with Cornerstone Robotics for their Sentire surgical robot, outside the U.S. JORDAN: This one got some pointed questions on the call. One analyst basically asked, "Does this mean you've lost confidence in Hugo, your own robot?" And Martha pushed back hard — said it's the opposite. Hugo's on track to hit 50,000 procedures by year-end, growing at twice the market rate. Cornerstone is about extending reach into international markets where Hugo isn't the right fit, not replacing it. ALEX: Basically building a multi-platform robotics portfolio instead of betting everything on one system. JORDAN: Exactly — and Thierry noted the financial impact this year is minimal, mostly just some foregone interest on that investment, but they expect real revenue and margin lift starting in fiscal 2028. ALEX: The second deal was Pi-Cardia, in structural heart — first FDA-cleared technology for leaflet modification in TAVR procedures for patients at risk of coronary obstruction. That's part of a broader doubling-down in structural heart, alongside their earlier investment in Anteris. JORDAN: On guidance, they ra This episode includes AI-generated content.

  ListenShow Notes
• 

  Beta Finch - S&P 100 - EN

  Exxon Mobil Q2 2026 Earnings Analysis

  Jul 31, 20266 min

  More earnings analysis: https://betafinch.com Groups: ENERGY ( https://betafinch.com/groups/ENERGY) ────────── ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown for the companies moving the market. I'm Alex, joined as always by Jordan. Today we're diving into ExxonMobil's second quarter 2026 results — and this one's a doozy, because the backdrop was serious geopolitical disruption. Before we get into it — this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions. JORDAN: Yeah, so let's set the scene. This quarter played out against the Middle East conflict, which knocked out roughly 10% of Exxon's upstream production. That's a huge hit operationally. ALEX: Right, but here's the headline — despite losing a tenth of their production, Exxon still posted $14.5 billion in earnings and $23.6 billion in cash flow from operations. That's industry-leading, disruption or not. JORDAN: It really speaks to the diversification strategy. Outside the Middle East, upstream production actually hit its highest level in over two decades. And chemical margins jumped about 180% quarter-over-quarter because their North American plants stepped in to cover the supply shortfall. ALEX: Let's talk Guyana, because this was the star of the Q&A. Production hit about 900,000 barrels a day gross, a fifth FPSO — that's a floating production vessel — set sail in June, and there's already talk of a ninth one being evaluated. JORDAN: The really interesting nugget is what CFO Neil Hansen called an "inflection point." Exxon has now recovered its full $55 billion investment in Guyana almost two years ahead of schedule. Under the contract structure, once you hit that recovery cap, more of the revenue flows straight to free cash flow instead of being funneled back into cost recovery. ALEX: So less volume growth going forward, but way more cash hitting the bottom line. JORDAN: Exactly — management was clear multiple times: "this is about value, not volume." They're projecting free cash flow from Guyana to roughly double by 2030 compared to 2025. ALEX: Now, refining — this is where it got really interesting given the Strait of Hormuz situation. CEO Darren Woods pointed out there's about 3 million barrels a day of refining capacity offline globally right now between the Strait closure, China halting exports, and Ukraine's strikes on Russian refineries. JORDAN: And Exxon's positioned well for that because of a decade of portfolio high-grading — they shed weaker refineries and invested in the strong ones. Their Gulf Coast operations ran at over 95% reliability this quarter and delivered record second-quarter diesel production. ALEX: One analyst pushed back a bit, though, noting refining earnings looked softer than some peers expected. Management chalked that up to volatility making margins hard to model in the moment, not any underlying operational issue. JORDAN: Specialty products was actually a quiet standout — record quarterly and first-half earnings, best-ever basestock margins. Their integrated value chain let them pivot around the crude supply disruptions better than competitors. ALEX: There was also a notable corporate move — Exxon officially redomiciled from New Jersey to Texas on July 1st, aligning their legal home with where they've actually operated for decades. Shareholders overwhelmingly approved it. JORDAN: And don't sleep on the cost story. Structural cost savings are now at $16.3 billion cumulative since 2019, on track for $20 billion by 2030. They're basically holding cash costs flat year-over-year despite inflation and continued growth spending — that's the discipline that's funded all this shareholder return. ALEX: Speaking of which — over $9 billion returned to shareholders this quarter through dividends and buybacks, plus more than This episode includes AI-generated content.

  ListenShow Notes

Recent guests on Beta Finch - S&P 100 - EN. Study who booked and why before you pitch.

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.